A Multicentre Study of Diclofenac Sodium Slow-Release (Voltaren® Retard) in the Treatment of Rheumatic Disorders in the Kingdom of Saudi Arabia

Artman A P Astroga G Badia J Gentiletti R Loizzi I Pucar I Seda H (1979) Comparison of Voltaren® slow-release once daily and Voltaren® twice daily with placebo in rheumatoid patients. IXth European Congress on Rheumatology, Wiesbaden, p 50.

Delcambre B (1980) L'Observance de la therapeutique anti-inflammatoire en pathologie rhumatologique ches des patients traites en ambulatoire. Interet d'une prise quotidienne unique. Semaíne des Hopitaux Paris 56, 1563.

Hartman A P (1980). Wereldwijd CIBA-GEIGY (NL) 4, 10.

Jaffer N A (1983) Slow-release Diclofenac sodium (Voltaren®) in soft tissue rheumatism. A multicentre trial. Journal of the Pakistan Medical Association 33, 95.

Kohler G Mohing W (1980). Aktuelle Rheumatolgie 5, 151.

Machtey I Ouaknine L Sandowski U (1979) Diclofenac sodium (Voltaren®) (V) and Ketaprofen (K) in Osteoarthritis. A double-blind study. IXth European Congress on Rheumatology, Wiesbaden. Abstracts EULAR 1979, 141.

Maier R (1978) The pharmacology of diclofenac sodium (Voltarol) International Symposium, Tangier.

Mehrez H (1984) Single daily dose treatment of Spondylarthrosis read before ‘5th Seapal Congress of Rheumatology’ (In press).

Menasse R (1978) Pharmacological properties of diclofenac sodium and its metabolites. Scandinavian Journal of Rheumatology, Suppl. 22, 5.

Riess W Stierlin H Degen P (1978) Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scandinavian Journal of Rheumatology, Suppl. 22, 17.

Schubiger B I Ciccolunghi S N Tanner K (1980) Once daily dose treatment with a non-steroidal anti-rheumatic drug (diclofenac) in osteoarthrosis. Journal of International Medical Research 8, 167.

Sioufi A Stierlin H Schweizer A Botta I Degen P H Theobald W Brechbuler S (1982) Recent findings concerning clinically-relevant pharmacokinetics of diclofenac sodium. In: Kass E (Editor). Voltaren® New Findings, Symposium at 15th International Congress of Rheumatology, Paris, 1981. Huber (Bern/Stuttgart, Vienna 1982). p 19.

Stierlin H Faigle J W Colombi A (1978) Pharmacokinetics of diclofenac sodium (Voltaren®) and metabolites in patients with impaired renal function. Scandinavian Journal of Rheumatology, Suppl. 22, 30.

Tausch G Ebner W (1980). Verhandlungen der Deutschen Gesellschaft fuer Rheumatologie 6, 350.

Tsuzuki M Yoshida S Takata S Narita R (1973) Clinical trial of GP 45A 840 — a new analgesic anti-inflammatory agent. Shikai Teubo (Prospect of dental field) 41, 14.